Polynovo (Polynovo) Interest Expense : $-0.10 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Polynovo Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Polynovo's interest expense for the six months ended in Dec. 2023 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Polynovo's Operating Income for the six months ended in Dec. 2023 was $ -0.11 Mil. Polynovo's Interest Expense for the six months ended in Dec. 2023 was $ -0.04 Mil. Polynovo did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Polynovo Interest Expense Historical Data

The historical data trend for Polynovo's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Interest Expense Chart

Polynovo Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.17

-0.16

-0.13

Polynovo Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.08	-0.08	-0.07	-0.06	-0.04

Polynovo Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.10 Mil.

Polynovo (OTCPK:CALZF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Polynovo's Interest Expense for the six months ended in Dec. 2023 was $-0.04 Mil. Its Operating Income for the six months ended in Dec. 2023 was $-0.11 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was $9.17 Mil.

Polynovo's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Polynovo did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Polynovo (Polynovo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MFJ:Germany PNV:Australia

Address

320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207

Website

https://www.polynovo.com

Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.